Skip to content

MaxCyte MXCT Earnings yield

Earnings yield at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.2%+1.2pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.8%+0.3pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-80.2%-24.4pp
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
-7.2%-3.3pp
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-48.6%+15.1pp
PDE
Pro-Dex, Inc.PDEX
7.6%+1.8pp

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%
P/S-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Operating margin-141.8%+6.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

Based on trailing twelve months.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's earnings yield?
MaxCyte (MXCT) reported earnings yield of -52.1% in Q1 2026.
How has MaxCyte's earnings yield changed year-over-year?
MaxCyte's earnings yield decreased by 260.9% year-over-year, from -14.4% to -52.1%.
What is the long-term trend for MaxCyte's earnings yield?
Over 4 years (2021 to 2025), MaxCyte's earnings yield has grown at a 95.5% compound annual growth rate (CAGR), from -1.8% to -27%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.